Trial Profile
A trial to study bioequivalence of fixed dose combination (Fdc) tablets of linagliptin/metformin extended release compared with the free combinations in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Apr 2016
Price :
$35
*
At a glance
- Drugs Linagliptin/metformin (Primary) ; Linagliptin; Metformin
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 20 Apr 2016 New trial record
- 12 Mar 2016 Results presented at the 117th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics